Congestive heart failure (CHF) is associated with prolonged and recurrent hospitalizations, the prognosis remains poor.

Analysis of epidemiology, healthcare consumption and prognosis at one year of a cohort of hospitalized patients for congestive heart failure in Saint Joseph Hospital (SHJ), using the SNDS data base (National data base).

From September 2016 to September 2018 all patients hospitalized for CHF in SJH were included. CHF was assessed by ESC criteria. Clinical and biological data were collected from the electronic health record. The follow up was one year. At this date, using SNDS data base, were collected mortality, re-hospitalization for CHF, re-hospitalization for other reason, drug prescription, healthcare consumption.

Six hundred and fifteen patients were included, 287 female (46.7%), the mean age 78.43 years (±11.10). Mean Ejection Fraction (EF) was 45.3% (±15.0), 199patients (32.36%) with preserved EF, ischemic disease for 370 patients (60.2%), 275 (44.7%) were in sinus rhythm. At discharge median BNP was 350.0ng/ml [174;770], mean Hemoglobin 12.4g/dl (±1.82), 323 patients (52.5%) with anemia (Hb<12g/dl). At one year the rates of drug consumption were for Conversion enzymeinhibitor or Angiotensine receptor antagonist 65.0%, loop diuretics 93.0%, spironolactone/eplerenone 27.7%, beta blocker 70.2%, oral direct anticoagulant34.9%, AVK 29.1%, antiplatelet agent 42.3%. At one year 563 patients (91.5%) had a general practitioner (GP) consultation (CS), the median number of GP CSwas 11 [7.0; 16.0], the median delay for the first GP CS was 13.0 days [6.0; 39.5], 400 (65%) had a cardiologist (C) CS, the median delay for the first C CSwas 55 days [28.0; 116.0]. Re-hospitalization rate for CHF was 36.75%, median delay 55 days [20.0; 156.2], 431 (70.0%) were re hospitalized for other reason atone year, median delay 61.0 days [20.0; 156.0], median number 2.0 [1.0; 4.0]. The mortality rate was 18.21%. The median delay of death occurrence was 137.0days [63.7; 240.0]. The composite index death or re-hospitalization concerned 484 (78.7%) patients of our cohort (Figure 1).

Our study confirmed that the CHF population had a poor prognosis despite health care policy and programs. Qualitative and quantitative improvement of the care pathway are needed.